SCF + G-CSF treatment in the chronic phase of severe TBI enhances axonal sprouting in the spinal cord and synaptic pruning in the hippocampus

Acta Neuropathol Commun. 2021 Apr 8;9(1):63. doi: 10.1186/s40478-021-01160-3.

Abstract

Traumatic brain injury (TBI) is a major cause of long-term disability in young adults. An evidence-based treatment for TBI recovery, especially in the chronic phase, is not yet available. Using a severe TBI mouse model, we demonstrate that the neurorestorative efficacy of repeated treatments with stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF) (SCF + G-CSF) in the chronic phase is superior to SCF + G-CSF single treatment. SCF + G-CSF treatment initiated at 3 months post-TBI enhances contralesional corticospinal tract sprouting into the denervated side of the cervical spinal cord and re-balances the TBI-induced overgrown synapses in the hippocampus by enhancing microglial function of synaptic pruning. These neurorestorative changes are associated with SCF + G-CSF-improved somatosensory-motor function and spatial learning. In the chronic phase of TBI, severe TBI-caused microglial degeneration in the cortex and hippocampus is ameliorated by SCF + G-CSF treatment. These findings reveal the therapeutic potential and possible mechanism of SCF + G-CSF treatment in brain repair during the chronic phase of severe TBI.

Keywords: Corticospinal tract; Granulocyte colony-stimulating factor; Stem cell factor; Synaptic pruning; Traumatic brain injury.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Axons / drug effects
  • Brain Injuries, Traumatic / pathology*
  • Granulocyte Colony-Stimulating Factor / pharmacology*
  • Hippocampus / drug effects
  • Hippocampus / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nerve Regeneration / drug effects*
  • Neuronal Plasticity / drug effects*
  • Neuroprotective Agents / pharmacology
  • Spinal Cord / drug effects
  • Spinal Cord / pathology
  • Stem Cell Factor / pharmacology*

Substances

  • Neuroprotective Agents
  • Stem Cell Factor
  • Granulocyte Colony-Stimulating Factor